Compare Humana Inc (HUM) vs Okta, Inc. (OKTA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Okta, Inc. — how do they compare? Humana Inc trades at $407.19 (market cap $47.81B), while Okta, Inc. trades at $140.73 (market cap $25.79B). The key difference: Humana Inc is the larger of the two by market cap, and Humana Inc pays a 0.89% dividend while Okta, Inc. pays none. Which is the better fit depends on your goals.
| HUM | OKTA | |
|---|---|---|
Market Cap | $47.81B | $25.79B |
Sector | Health | Technology |
52-Week High | $409.42 | $154.62 |
52-Week Low | $163.67 | $62.93 |
Enterprise Value | $56.85B | $23.62B |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $398.09, down 0.48% with a bullish technical signal from moving averages. The company shows strong revenue growth to $129.66B in 2025 but faces margin compression with net income margin declining to 0.82%. Recent earnings have consistently beaten expectations, and analyst sentiment is mixed with 34% buy ratings but a consensus price target of $354.33 below current levels.
The outlook suggests cautious optimism with Medicare Advantage expansion opportunities but significant margin pressure and regulatory risks. Key investment considerations include the company's ability to achieve its 3% Medicare Advantage margin target by 2028 while navigating increased healthcare utilization costs and competitive pressures in the insurance sector.
OKTA trades at $150.64, up 0.86% today, with a bullish technical outlook supported by moving averages and strong institutional sentiment. The company has beaten earnings estimates for three consecutive quarters, with Q2 2026 EPS expected at $0.96. Revenue growth accelerated to $2.61B in 2025, achieving positive net income of $28M after years of losses, while operating cash flow surged to $750M. Recent news highlights AI-driven cybersecurity demand boosting Okta's identity protection solutions.
Outlook is positive given earnings momentum and sector tailwinds, but high valuation multiples (P/E 108.22) pose risks if growth slows. Analyst consensus is strongly bullish with a $125.78 price target, though competitive pressures and macroeconomic volatility remain key watchpoints for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Okta, Inc.
Okta is a cloud-native security company that focuses on identity and access management. The San Francisco-based firm went public in 2017 and focuses on two key client stakeholder groups: workforces and customers. Okta's workforce offerings enable a company's employees to securely access its cloud-based and on-premises resources. The firm's customer offerings allow its clients' customers to securely access the client's applications.
Read more on OKTA →
